Markets:

Overview

News

Currencies

International

Treasuries

Enveric Biosciences, Inc. - Common Stock (NQ:ENVB)

2.240 +0.160 (+7.69%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Enveric Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Enveric Biosciences Expands Collaboration with TOTEC Pharma through Trademark License and Option

January 29, 2026

From Enveric Biosciences

Via Business Wire

Enveric Biosciences Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

January 28, 2026

From Enveric Biosciences, Inc.

Via Business Wire

Top movers analysis in the middle of the day on 2026-01-28: top gainers and losers in today's session. ↗

January 28, 2026

Via Chartmill

Why Did ENVB Stock More Than Double In Value Today? ↗

December 10, 2025

Via Stocktwits

Gapping stocks in Wednesday's session ↗

January 28, 2026

Via Chartmill

Enveric Biosciences Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

January 28, 2026

From Enveric Biosciences, Inc.

Via Business Wire

Why Is ENVB Stock Rising Today? ↗

December 29, 2025

The company said that U.S. Patent No. 12,492,179 extends the protection for its pipeline of potentially neuroplastogenic, non-hallucinogenic molecules.

Via Stocktwits

Topics Intellectual Property

Enveric Biosciences Announces Patent Issuance

December 29, 2025

From Enveric Biosciences

Via Business Wire

The Great Migration: Why International Tech and Biotech Giants are Redomiciling to the Massachusetts Hub

December 23, 2025

The global financial landscape is witnessing a seismic shift as international corporations increasingly abandon their home markets to "onshore" in the United States. At the heart of this movement is...

Via MarketMinute

Topics Economy Initial Public Offering

Enveric Biosciences Announces Closing of Exercise of Warrants for $3.1 Million Gross Proceeds

December 12, 2025

From Enveric Biosciences, Inc.

Via Business Wire

Top movers analysis one hour before the close of the markets on 2025-12-11: top gainers and losers in today's session. ↗

December 11, 2025

Curious to know what's happening on the US markets one hour before the close of the markets on Thursday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

Enveric Biosciences Announces Exercise of Warrants for $3.1 Million Gross Proceeds

December 11, 2025

From Enveric Biosciences, Inc

Via Business Wire

These stocks are moving in today's session ↗

December 10, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Keep an eye on the top gainers and losers in Wednesday's session. ↗

December 10, 2025

Wondering how the US markets performed in the middle of the day on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Traders are paying attention to the gapping stocks in Wednesday's session. ↗

December 10, 2025

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Wednesday.

Via Chartmill

These stocks that are showing activity before the opening bell on Wednesday. ↗

December 10, 2025

Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.

Via Chartmill

Enveric Biosciences Receives Notice of Allowance for EVM301 Series of Drug Candidates

December 09, 2025

From Enveric Biosciences

Via Business Wire

Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 9th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2026”

December 04, 2025

From Enveric Biosciences

Via Business Wire

Enveric Biosciences Receives Fourth Notice of Allowance for EVM401 Series of Drug Candidates

November 26, 2025

From Enveric Biosciences

Via Business Wire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 19, 2025

Via Benzinga

Enveric Biosciences Reports Third Quarter 2025 Financial and Corporate Results

November 14, 2025

From Enveric Biosciences

Via Business Wire

Which stocks are moving on Monday? ↗

November 03, 2025

Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

Enveric Biosciences Announces Reverse Stock Split

October 23, 2025

From Enveric Biosciences

Via Business Wire

Enveric Biosciences Further Enhances Intellectual Property Estate with New U.S. Patent Issuance

October 16, 2025

From Enveric Biosciences

Via Business Wire

Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal

October 15, 2025

From Enveric Biosciences

Via Business Wire

Enveric Biosciences to Explore Digital Asset Treasury Opportunities

October 14, 2025

From Enveric Biosciences

Via Business Wire

These stocks are gapping in today's session ↗

October 03, 2025

Traders are paying attention to the gapping stocks in Friday's session. Let's dive into which stocks are experiencing notable gaps.

Via Chartmill

These stocks that are showing activity before the opening bell on Friday. ↗

October 03, 2025

Wondering what's happening in Friday's pre-market session? Find an overview in this article.

Via Chartmill

Enveric Biosciences Successfully Completes Key Manufacturing Milestones in Support of Planned IND and Clinical Trials

October 02, 2025

From Enveric Biosciences

Via Business Wire

Stay updated with the stocks that are on the move in today's pre-market session. ↗

September 30, 2025

The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.